
Widespread image manipulation by laboratory supply companies, specifically concerning antibodies, undermines the reliability of scientific research and development, potentially leading to wasted R&D budgets and flawed therapeutic or diagnostic pipelines for biotech and pharmaceutical investors.
An AI breakdown of exactly what changed and who it moves.